Sepranolone - Asarina Pharma

Drug Profile

Sepranolone - Asarina Pharma

Alternative Names: Isoallopregnanolone; UC1010

Latest Information Update: 05 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Umecrine Mood
  • Developer Asarina Pharma
  • Class Antidepressants
  • Mechanism of Action GABA-A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Premenstrual dysphoric disorder

Most Recent Events

  • 22 Nov 2017 Phase-II clinical trials in Premenstrual dysphoric disorder in Germany (SC) (EudraCT2017-000822-37)
  • 15 Apr 2016 Phase-II clinical trials in Premenstrual dysphoric disorder in Sweden (SC)
  • 29 Apr 2014 Umecrine Mood completes a phase I/II trial in Premenstrual dysphoric disorder in Sweden (EudraCT2012-004081-18)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top